Patienter skal underrettes om, at det ikke er påvist, at behandling med adefovirdipivoxil reducerer risikoen for at smitte andre med hepatitis B virus, og at der derfor fortsat skal anvendes hensigtsmæssige forsigtighedsregler.
Patients should be advised that therapy with adefovir dipivoxil has not been proven to reduce the risk of transmission of hepatitis B virus to others and therefore appropriate precautions should still be taken.